Pennsylvania Supreme Court Won't Review $10.5M Prempro Breast Cancer Verdict

Pennsylvania Supreme Court Won't Review $10.5M Prempro Breast Cancer Verdict

PHILADELPHIA - The Pennsylvania Supreme Court on Oct. 16 denied drug manufacturer Wyeth's petition to appeal a $10.5 million hormone replacement therapy verdict in favor of a breast cancer plaintiff (Connie J. Barton v. Wyeth Pharmaceuticals, Inc., et al., Nos. 176 EAL 2012 and 177 EAL 2012, Pa. Sup., Eastern Dist.).

Find full version on lexis Advance®
Access this news story on lexis.com®